SARS-CoV-2 Ct values and COVID-19 symptoms in patients with haematological malignancies in South Africa
The findings suggest a potential benefit in delaying chemotherapy at any Ct value as patients could present with acute SARS-CoV-2 infection at higher Ct values, and therefore face increased risk of adverse outcomes with early chemotherapy initiation.
Authors
- Jeannette Wadula (ORCID: https://orcid.org/0000-0002-1083-6173)
- Sarah Alexandra van Blydenstein (ORCID: https://orcid.org/0000-0003-3388-6218)
- Vinitha Philip (ORCID: https://orcid.org/0009-0008-5503-9291)
- Keitumetsi Lucy Sothoane (ORCID: https://orcid.org/0009-0009-1297-0040)
Institutions
- National Health Laboratory Service (ZA)
- University of the Witwatersrand (ZA)
- Chris Hani Baragwanath Hospital (ZA)
Publication Details
- Journal
- Southern African Journal of Infectious Diseases
- Published
- 2025-01-09
- DOI
- https://doi.org/10.4102/sajid.40i1.676
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Health Laboratory Service